1. The Relationship between Nutritional Parameters and Thrombosis Risk in Cancer Patients. (21st April 2022) Authors: Sari, Merve; Ilhan, Yusuf; Sezgin Goksu, Sema; Kostek, Osman; Tatli, Ali Murat; Coskun, Hasan Senol Journal: Nutrition and cancer Issue: Volume 74:Number 4(2022) Page Start: 1370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group. Issue 50 (16th December 2022) Authors: Gürbüz, Mustafa; Kiliçkap, Saadettin; Bilici, Ahmet; Karadurmuş, Nuri; Sezer, Ahmet; Şendur, Mehmet Ali Nahit; Paydaş, Semra; Artaç, Mehmet; Fulden Yumuk, Perran; Gürsoy, Pinar; Uysal, Mükremin; Şenol Coşkun, Hasan; Tatli, Ali Murat; Selçukbiricik, Fatih; Dişel, Umut; Köksoy, Elif Berna; Güven, D... Journal: Medicine Issue: Volume 101:Issue 50(2022) Page Start: e32368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association of Vitiligo and Response in Patients with Metastatic Malignant Melanoma on Temozolomide. Issue 2 (March 2015) Authors: Tatli, Ali Murat; Besen, Ali Ayberk; Kalender, Mehmet Emin; Uysal, Mukremin; Asian, Deniz; Goksu, Sema Sezgin; Gunduz, Seyda Gulenay; Coskun, Hasan Senol Journal: Tumori Issue: Volume 101:Issue 2(2015) Page Start: e67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer. Issue 2 (March 2023) Authors: Akagündüz, Baran; Guven, Deniz Can; Ozer, Muhammet; Okten, Ilker Nihat; Atag, Elif; Unek, İlkay Tugba; Tatli, Ali Murat; Karaoglu, Aziz Journal: Journal of geriatric oncology Issue: Volume 14:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer. Issue 4 (27th January 2022) Authors: Ilhan, Yusuf; Tatli, Ali Murat; Teker, Fatih; Onder, Arif Hakan; Kose, Fatih; Geredeli, Caglayan; Karaagac, Mustafa; Kaplan, Muhammet Ali; Inanc, Mevlude; Goktas Aydin, Sabin; Kargi, Aysegul; Arak, Hacı; Ozturk, Banu; Besen, Ali Ayberk; Selvi, Oguzhan; Korkmaz, Mustafa; Oruc, Zeynep; Bozkurt, Okt... Journal: International journal of gynecological cancer Issue: Volume 32:Issue 4(2022) Page Start: 502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗